Pioglitazone Ameliorates Smooth Muscle Cell Proliferation in Cuff-Induced Neointimal Formation by Both Adiponectin-Dependent and -Independent Pathways
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pioglitazone Ameliorates Smooth Muscle Cell Proliferation in Cuff-Induced Neointimal Formation by Both Adiponectin-Dependent and -Independent Pathways
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-10-05
DOI
10.1038/srep34707
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling
- (2016) Islam Osman et al. BIOCHEMICAL PHARMACOLOGY
- Hydrochloride pioglitazone protects diabetic rats against podocyte injury through preserving glomerular podocalyxin expression
- (2014) Yan Xing et al. Arquivos Brasileiros de Endocrinologia e Metabologia
- Pioglitazone modulates the proliferation and apoptosis of vascular smooth muscle cells via peroxisome proliferators-activated receptor-gamma
- (2014) Jing Wan et al. Diabetology & Metabolic Syndrome
- Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs
- (2012) Xuhua Shen et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Adiponectin and cardiovascular health: an update
- (2011) Xiaoyan Hui et al. BRITISH JOURNAL OF PHARMACOLOGY
- Adiponectin Inhibits PDGF-induced Mesangial Cell Proliferation: Regulation of Mammalian Target of Rapamycin-mediated Survival Pathway by Adenosine 5-Monophosphate-activated Protein Kinase
- (2011) Y.-X. Su et al. HORMONE AND METABOLIC RESEARCH
- Vascular Smooth Muscle Cell Peroxisome Proliferator–Activated Receptor-γ Mediates Pioglitazone-Reduced Vascular Lesion Formation
- (2010) Milton Hamblin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Pioglitazone-Induced Reductions in Atherosclerosis Occur via Smooth Muscle Cell–Specific Interaction With PPARγ
- (2010) Venkateswaran Subramanian et al. CIRCULATION RESEARCH
- Pioglitazone increases apolipoprotein A-I production by directly enhancing PPRE-dependent transcription in HepG2 cells
- (2010) Lin-Hua Zhang et al. JOURNAL OF LIPID RESEARCH
- Adiponectin Represses Colon Cancer Cell Proliferation via AdipoR1- and -R2-Mediated AMPK Activation
- (2010) A Young Kim et al. MOLECULAR ENDOCRINOLOGY
- Krüppel-like factor (KLF) 5 mediates cyclin D1 expression and cell proliferation via interaction with c-Jun in Ang II-induced VSMCs
- (2009) Yu Liu et al. ACTA PHARMACOLOGICA SINICA
- Evidence for the Importance of Adiponectin in the Cardioprotective Effects of Pioglitazone
- (2009) Ping Li et al. HYPERTENSION
- Adiponectin Protects Against Angiotensin II–Induced Cardiac Fibrosis Through Activation of PPAR-α
- (2008) Koichi Fujita et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- PIOGLITAZONE INHIBITS HOMOCYSTEINE-INDUCED MIGRATION OF VASCULAR SMOOTH MUSCLE CELLS THROUGH A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ-INDEPENDENT MECHANISM
- (2008) Li Li et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Thiazolidinediones—improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes
- (2008) Paresh Dandona et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started